doi: 10.1038/s41392-024-01931-z, Summary Keywords central nervous system, feeding behavior, GLP-1 receptor agonists, gutbrain axis, obesity Citation OConnor RM (2026) Revisiting food addiction in the era of GLP-1based obesity pharmacotherapy via neural reward pathways linking feeding and substance use
Whether you choose medication, supplements, or a combination, the best outcome comes from personalized assessment, ongoing monitoring, and supporting the whole person (diet, activity, stress, sleep, digestion, nutrient status)
What should you do next if you are considering long-term Semaglutide
The FDA-approved titration schedule allows your body to adjust while building up to the therapeutic maintenance dose of 2.4 mg weekly
Avoid Triggers: Pay attention to which foods might trigger side effects
MASLD is the most common chronic liver disease in children, the rates continue to rise and is the fastest growing indication for liver transplant specifically in young adults , Andrea M